EVER vs. HSTM, EB, MODN, HCAT, SVMK, DV, RUM, TRIP, WB, and MGNI
Should you be buying EverQuote stock or one of its competitors? The main competitors of EverQuote include HealthStream (HSTM), Eventbrite (EB), Model N (MODN), Health Catalyst (HCAT), SVMK (SVMK), DoubleVerify (DV), Rumble (RUM), Tripadvisor (TRIP), Weibo (WB), and Magnite (MGNI).
EverQuote (NASDAQ:EVER) and HealthStream (NASDAQ:HSTM) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation, community ranking and profitability.
HealthStream has a net margin of 6.30% compared to EverQuote's net margin of -17.37%. HealthStream's return on equity of 5.21% beat EverQuote's return on equity.
HealthStream has lower revenue, but higher earnings than EverQuote. EverQuote is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.
EverQuote has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500.
EverQuote presently has a consensus target price of $26.25, suggesting a potential upside of 9.88%. HealthStream has a consensus target price of $32.00, suggesting a potential upside of 17.26%. Given HealthStream's higher probable upside, analysts clearly believe HealthStream is more favorable than EverQuote.
91.5% of EverQuote shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 29.8% of EverQuote shares are owned by insiders. Comparatively, 20.6% of HealthStream shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
HealthStream received 414 more outperform votes than EverQuote when rated by MarketBeat users. However, 69.35% of users gave EverQuote an outperform vote while only 66.62% of users gave HealthStream an outperform vote.
In the previous week, EverQuote had 11 more articles in the media than HealthStream. MarketBeat recorded 16 mentions for EverQuote and 5 mentions for HealthStream. EverQuote's average media sentiment score of 0.89 beat HealthStream's score of 0.15 indicating that EverQuote is being referred to more favorably in the media.
Summary
EverQuote and HealthStream tied by winning 9 of the 18 factors compared between the two stocks.
Get EverQuote News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVER and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
EverQuote Competitors List
Related Companies and Tools
